Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMFL2P)

Drug Name
Anti-CD7 CAR-T cells Drug Info
Indication
Disease Entry ICD 11 Status REF
leukaemia 2A60-2B33 Phase 1 [1]
Lymphoma 2A80-2A86 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMMFL2P

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting T-cell antigen CD7 (CD7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CD7.CAR/28zeta CAR T cells DMHTNLJ B-cell acute lymphoblastic leukaemia 2B33.3 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
T-cell antigen CD7 (CD7) TTP6B8O CD7_HUMAN CAR-T-Cell-Therapy [1]

References

1 ClinicalTrials.gov (NCT03121625) CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
2 ClinicalTrials.gov (NCT03690011) Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells